SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-013719
Filing Date
2024-04-29
Accepted
2024-04-29 16:32:56
Documents
20
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A tgtx20240423_def14a.htm   iXBRL DEF 14A 935875
6 capvsnetincomesmall.jpg GRAPHIC 35926
7 p01.jpg GRAPHIC 237339
8 p02.jpg GRAPHIC 209554
9 picture1capvstsrsmall.jpg GRAPHIC 37185
10 picture5capvscsfmsmall.jpg GRAPHIC 34453
11 tgtxlogo01.jpg GRAPHIC 6027
  Complete submission text file 0001437749-24-013719.txt   3121969

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20231231.xsd EX-101.SCH 2751
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20231231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20231231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20231231_pre.xml EX-101.PRE 714
23 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20240423_def14a_htm.xml XML 202807
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 24891544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)